Musk startup Neuralink says it's been cleared to test brain implants in humans

Elon Musk's start-up Neuralink on Thursday said it has approval from U.S. regulators to test its brain implants in people.

Neuralink said clearance from the Food and Drug Administration for its first in-human clinical study is "an important first step" for its technology, which is intended to enable brains to interface directly with computers.

"We are excited to share that we have received the FDA's approval to launch our first-in-human clinical study," Neuralink said in a post on Musk-run Twitter.